Also from this source

You just read:

AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation

News provided by

AstraZeneca , Nektar Therapeutics

Mar 15, 2011, 12:06 ET